NCT00332540View on ClinicalTrials.gov

Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
Ocular Hypertension
Interventions
DRUG

bimatoprost/timolol fixed combination

Trial Locations (2)

Unknown

Rochester

Sherbrooke

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY